Organization Name Orbital TherapeuticsAnnounced Date Apr 26, 2023 Funding Type Series A Funding Stage Early Stage Venture Money Raised
Overview
Lead Investors
- ARCH Venture Partners
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Investors
Investor Name | Partners |
---|---|
Rellim Capital Management | |
Redmile Group | |
Newpath Management | |
Moore Strategic Ventures | |
Invus | |
iGlobe Partners | |
Heritage Medical Systems | |
EXOR N.V. | |
Casdin Capital | |
ARCH Venture Partners |
Recent News
Labiotech.eu — The biggest private biotech investments in April 2023
Pharmaceutical Technology — Orbital raises $270m investment for advancement of RNA medicines
lec33.com — 轨道公司筹集2.7亿美元用于开发基于基因的药物和疫苗
GEN - Genetic Engineering and Biotechnology News — RNA Gains Genetic Medicine Momentum with News from Orbital, MiNA, BioMarin
Pharma Letter — Orbital Therapeutics secures $270 million financing